FENISTIL

Main information

  • Trade name:
  • FENISTIL Gel 1MG/G
  • Dosage:
  • 1MG/G
  • Pharmaceutical form:
  • Gel
  • Administration route:
  • Cutaneous use
  • Units in package:
  • 1X50G Tube
  • Prescription type:
  • OTC medicinal products
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FENISTIL Gel 1MG/G
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • DIMETINDEN
  • Product summary:
  • FENISTIL

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 46/ 130/92-S/C
  • Authorization date:
  • 01-06-2017
  • EAN code:
  • 8596149002040
  • Last update:
  • 21-06-2017

28-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Europe - EMA - European Medicines Agency

30-7-2018

Apoquel (Zoetis Belgium S.A.)

Apoquel (Zoetis Belgium S.A.)

Apoquel (Active substance: Oclacitinib maleate) - Centralised - Renewal - Commission Decision (2018)5153 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2688/R/13

Europe -DG Health and Food Safety